脱毛治療薬の世界市場見通し2023年-2029年

◆英語タイトル:Hair Loss Medications Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書(MMG23JU5602)◆商品コード:MMG23JU5602
◆発行会社(リサーチ会社):Market Monitor Global
◆発行日:2023年6月
◆ページ数:74
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野:医薬品&医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Hair Loss Medications Market 調査レポートは次の情報を含め、グローバルにおけるの脱毛治療薬市場規模と予測を収録しています。・世界の脱毛治療薬市場:売上、2018年-2023年、2024年-2029年
・世界の脱毛治療薬市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の脱毛治療薬市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「Rx」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

脱毛治療薬のグローバル主要企業は、Merck、 Johnson & Johnson、 Gerolymatos International、 Nanogen、 Oxford BioLabs、 Ultrax Labs、 Bayer、 Pharma Medico、 Kirkland Signature、 Phyto Ales Group、 Amplixin、 Keranique、 DS Healthcare Groupなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、脱毛治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の脱毛治療薬市場:タイプ別、2018年-2023年、2024年-2029年
世界の脱毛治療薬市場:タイプ別市場シェア、2022年
・Rx、OTC

世界の脱毛治療薬市場:用途別、2018年-2023年、2024年-2029年
世界の脱毛治療薬市場:用途別市場シェア、2022年
・男性、女性、両方

世界の脱毛治療薬市場:地域・国別、2018年-2023年、2024年-2029年
世界の脱毛治療薬市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における脱毛治療薬のグローバル売上、2018年-2023年
・主要企業における脱毛治療薬のグローバル売上シェア、2022年
・主要企業における脱毛治療薬のグローバル販売量、2018年-2023年
・主要企業における脱毛治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Merck、 Johnson & Johnson、 Gerolymatos International、 Nanogen、 Oxford BioLabs、 Ultrax Labs、 Bayer、 Pharma Medico、 Kirkland Signature、 Phyto Ales Group、 Amplixin、 Keranique、 DS Healthcare Group

*************************************************************

・調査・分析レポートの概要
脱毛治療薬市場の定義
市場セグメント
世界の脱毛治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の脱毛治療薬市場規模
世界の脱毛治療薬市場規模:2022年 VS 2029年
世界の脱毛治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの脱毛治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の脱毛治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:Rx、OTC
脱毛治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:男性、女性、両方
脱毛治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別脱毛治療薬市場規模 2022年と2029年
地域別脱毛治療薬売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報(企業概要、事業概要、主要製品、売上、ニュースなど)
Merck、 Johnson & Johnson、 Gerolymatos International、 Nanogen、 Oxford BioLabs、 Ultrax Labs、 Bayer、 Pharma Medico、 Kirkland Signature、 Phyto Ales Group、 Amplixin、 Keranique、 DS Healthcare Group
...

Hair Loss Medications are mainy two types: Minoxidil (Rogaine) Finasteride (Propecia, Proscar).
This report aims to provide a comprehensive presentation of the global market for Hair Loss Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hair Loss Medications. This report contains market size and forecasts of Hair Loss Medications in global, including the following market information:
Global Hair Loss Medications Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Hair Loss Medications Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Hair Loss Medications companies in 2022 (%)
The global Hair Loss Medications market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Rx Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hair Loss Medications include Merck, Johnson & Johnson, Gerolymatos International, Nanogen, Oxford BioLabs, Ultrax Labs, Bayer, Pharma Medico and Kirkland Signature, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hair Loss Medications manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hair Loss Medications Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hair Loss Medications Market Segment Percentages, by Type, 2022 (%)
Rx
OTC
Global Hair Loss Medications Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hair Loss Medications Market Segment Percentages, by Application, 2022 (%)
Male
Female
Both
Global Hair Loss Medications Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hair Loss Medications Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hair Loss Medications revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hair Loss Medications revenues share in global market, 2022 (%)
Key companies Hair Loss Medications sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Hair Loss Medications sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Johnson & Johnson
Gerolymatos International
Nanogen
Oxford BioLabs
Ultrax Labs
Bayer
Pharma Medico
Kirkland Signature
Phyto Ales Group
Amplixin
Keranique
DS Healthcare Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hair Loss Medications, market overview.
Chapter 2: Global Hair Loss Medications market size in revenue and volume.
Chapter 3: Detailed analysis of Hair Loss Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hair Loss Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hair Loss Medications capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Hair Loss Medications Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hair Loss Medications Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hair Loss Medications Overall Market Size
2.1 Global Hair Loss Medications Market Size: 2022 VS 2029
2.2 Global Hair Loss Medications Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Hair Loss Medications Sales: 2018-2029
3 Company Landscape
3.1 Top Hair Loss Medications Players in Global Market
3.2 Top Global Hair Loss Medications Companies Ranked by Revenue
3.3 Global Hair Loss Medications Revenue by Companies
3.4 Global Hair Loss Medications Sales by Companies
3.5 Global Hair Loss Medications Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hair Loss Medications Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hair Loss Medications Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hair Loss Medications Players in Global Market
3.8.1 List of Global Tier 1 Hair Loss Medications Companies
3.8.2 List of Global Tier 2 and Tier 3 Hair Loss Medications Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Hair Loss Medications Market Size Markets, 2022 & 2029
4.1.2 Rx
4.1.3 OTC
4.2 By Type – Global Hair Loss Medications Revenue & Forecasts
4.2.1 By Type – Global Hair Loss Medications Revenue, 2018-2023
4.2.2 By Type – Global Hair Loss Medications Revenue, 2024-2029
4.2.3 By Type – Global Hair Loss Medications Revenue Market Share, 2018-2029
4.3 By Type – Global Hair Loss Medications Sales & Forecasts
4.3.1 By Type – Global Hair Loss Medications Sales, 2018-2023
4.3.2 By Type – Global Hair Loss Medications Sales, 2024-2029
4.3.3 By Type – Global Hair Loss Medications Sales Market Share, 2018-2029
4.4 By Type – Global Hair Loss Medications Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Hair Loss Medications Market Size, 2022 & 2029
5.1.2 Male
5.1.3 Female
5.1.4 Both
5.2 By Application – Global Hair Loss Medications Revenue & Forecasts
5.2.1 By Application – Global Hair Loss Medications Revenue, 2018-2023
5.2.2 By Application – Global Hair Loss Medications Revenue, 2024-2029
5.2.3 By Application – Global Hair Loss Medications Revenue Market Share, 2018-2029
5.3 By Application – Global Hair Loss Medications Sales & Forecasts
5.3.1 By Application – Global Hair Loss Medications Sales, 2018-2023
5.3.2 By Application – Global Hair Loss Medications Sales, 2024-2029
5.3.3 By Application – Global Hair Loss Medications Sales Market Share, 2018-2029
5.4 By Application – Global Hair Loss Medications Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Hair Loss Medications Market Size, 2022 & 2029
6.2 By Region – Global Hair Loss Medications Revenue & Forecasts
6.2.1 By Region – Global Hair Loss Medications Revenue, 2018-2023
6.2.2 By Region – Global Hair Loss Medications Revenue, 2024-2029
6.2.3 By Region – Global Hair Loss Medications Revenue Market Share, 2018-2029
6.3 By Region – Global Hair Loss Medications Sales & Forecasts
6.3.1 By Region – Global Hair Loss Medications Sales, 2018-2023
6.3.2 By Region – Global Hair Loss Medications Sales, 2024-2029
6.3.3 By Region – Global Hair Loss Medications Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Hair Loss Medications Revenue, 2018-2029
6.4.2 By Country – North America Hair Loss Medications Sales, 2018-2029
6.4.3 US Hair Loss Medications Market Size, 2018-2029
6.4.4 Canada Hair Loss Medications Market Size, 2018-2029
6.4.5 Mexico Hair Loss Medications Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Hair Loss Medications Revenue, 2018-2029
6.5.2 By Country – Europe Hair Loss Medications Sales, 2018-2029
6.5.3 Germany Hair Loss Medications Market Size, 2018-2029
6.5.4 France Hair Loss Medications Market Size, 2018-2029
6.5.5 U.K. Hair Loss Medications Market Size, 2018-2029
6.5.6 Italy Hair Loss Medications Market Size, 2018-2029
6.5.7 Russia Hair Loss Medications Market Size, 2018-2029
6.5.8 Nordic Countries Hair Loss Medications Market Size, 2018-2029
6.5.9 Benelux Hair Loss Medications Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Hair Loss Medications Revenue, 2018-2029
6.6.2 By Region – Asia Hair Loss Medications Sales, 2018-2029
6.6.3 China Hair Loss Medications Market Size, 2018-2029
6.6.4 Japan Hair Loss Medications Market Size, 2018-2029
6.6.5 South Korea Hair Loss Medications Market Size, 2018-2029
6.6.6 Southeast Asia Hair Loss Medications Market Size, 2018-2029
6.6.7 India Hair Loss Medications Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Hair Loss Medications Revenue, 2018-2029
6.7.2 By Country – South America Hair Loss Medications Sales, 2018-2029
6.7.3 Brazil Hair Loss Medications Market Size, 2018-2029
6.7.4 Argentina Hair Loss Medications Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Hair Loss Medications Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Hair Loss Medications Sales, 2018-2029
6.8.3 Turkey Hair Loss Medications Market Size, 2018-2029
6.8.4 Israel Hair Loss Medications Market Size, 2018-2029
6.8.5 Saudi Arabia Hair Loss Medications Market Size, 2018-2029
6.8.6 UAE Hair Loss Medications Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Hair Loss Medications Major Product Offerings
7.1.4 Merck Hair Loss Medications Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Hair Loss Medications Major Product Offerings
7.2.4 Johnson & Johnson Hair Loss Medications Sales and Revenue in Global (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Gerolymatos International
7.3.1 Gerolymatos International Company Summary
7.3.2 Gerolymatos International Business Overview
7.3.3 Gerolymatos International Hair Loss Medications Major Product Offerings
7.3.4 Gerolymatos International Hair Loss Medications Sales and Revenue in Global (2018-2023)
7.3.5 Gerolymatos International Key News & Latest Developments
7.4 Nanogen
7.4.1 Nanogen Company Summary
7.4.2 Nanogen Business Overview
7.4.3 Nanogen Hair Loss Medications Major Product Offerings
7.4.4 Nanogen Hair Loss Medications Sales and Revenue in Global (2018-2023)
7.4.5 Nanogen Key News & Latest Developments
7.5 Oxford BioLabs
7.5.1 Oxford BioLabs Company Summary
7.5.2 Oxford BioLabs Business Overview
7.5.3 Oxford BioLabs Hair Loss Medications Major Product Offerings
7.5.4 Oxford BioLabs Hair Loss Medications Sales and Revenue in Global (2018-2023)
7.5.5 Oxford BioLabs Key News & Latest Developments
7.6 Ultrax Labs
7.6.1 Ultrax Labs Company Summary
7.6.2 Ultrax Labs Business Overview
7.6.3 Ultrax Labs Hair Loss Medications Major Product Offerings
7.6.4 Ultrax Labs Hair Loss Medications Sales and Revenue in Global (2018-2023)
7.6.5 Ultrax Labs Key News & Latest Developments
7.7 Bayer
7.7.1 Bayer Company Summary
7.7.2 Bayer Business Overview
7.7.3 Bayer Hair Loss Medications Major Product Offerings
7.7.4 Bayer Hair Loss Medications Sales and Revenue in Global (2018-2023)
7.7.5 Bayer Key News & Latest Developments
7.8 Pharma Medico
7.8.1 Pharma Medico Company Summary
7.8.2 Pharma Medico Business Overview
7.8.3 Pharma Medico Hair Loss Medications Major Product Offerings
7.8.4 Pharma Medico Hair Loss Medications Sales and Revenue in Global (2018-2023)
7.8.5 Pharma Medico Key News & Latest Developments
7.9 Kirkland Signature
7.9.1 Kirkland Signature Company Summary
7.9.2 Kirkland Signature Business Overview
7.9.3 Kirkland Signature Hair Loss Medications Major Product Offerings
7.9.4 Kirkland Signature Hair Loss Medications Sales and Revenue in Global (2018-2023)
7.9.5 Kirkland Signature Key News & Latest Developments
7.10 Phyto Ales Group
7.10.1 Phyto Ales Group Company Summary
7.10.2 Phyto Ales Group Business Overview
7.10.3 Phyto Ales Group Hair Loss Medications Major Product Offerings
7.10.4 Phyto Ales Group Hair Loss Medications Sales and Revenue in Global (2018-2023)
7.10.5 Phyto Ales Group Key News & Latest Developments
7.11 Amplixin
7.11.1 Amplixin Company Summary
7.11.2 Amplixin Hair Loss Medications Business Overview
7.11.3 Amplixin Hair Loss Medications Major Product Offerings
7.11.4 Amplixin Hair Loss Medications Sales and Revenue in Global (2018-2023)
7.11.5 Amplixin Key News & Latest Developments
7.12 Keranique
7.12.1 Keranique Company Summary
7.12.2 Keranique Hair Loss Medications Business Overview
7.12.3 Keranique Hair Loss Medications Major Product Offerings
7.12.4 Keranique Hair Loss Medications Sales and Revenue in Global (2018-2023)
7.12.5 Keranique Key News & Latest Developments
7.13 DS Healthcare Group
7.13.1 DS Healthcare Group Company Summary
7.13.2 DS Healthcare Group Hair Loss Medications Business Overview
7.13.3 DS Healthcare Group Hair Loss Medications Major Product Offerings
7.13.4 DS Healthcare Group Hair Loss Medications Sales and Revenue in Global (2018-2023)
7.13.5 DS Healthcare Group Key News & Latest Developments
8 Global Hair Loss Medications Production Capacity, Analysis
8.1 Global Hair Loss Medications Production Capacity, 2018-2029
8.2 Hair Loss Medications Production Capacity of Key Manufacturers in Global Market
8.3 Global Hair Loss Medications Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hair Loss Medications Supply Chain Analysis
10.1 Hair Loss Medications Industry Value Chain
10.2 Hair Loss Medications Upstream Market
10.3 Hair Loss Medications Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hair Loss Medications Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Hair Loss Medications in Global Market
Table 2. Top Hair Loss Medications Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Hair Loss Medications Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Hair Loss Medications Revenue Share by Companies, 2018-2023
Table 5. Global Hair Loss Medications Sales by Companies, (K Units), 2018-2023
Table 6. Global Hair Loss Medications Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Hair Loss Medications Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Hair Loss Medications Product Type
Table 9. List of Global Tier 1 Hair Loss Medications Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hair Loss Medications Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Hair Loss Medications Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Hair Loss Medications Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Hair Loss Medications Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Hair Loss Medications Sales (K Units), 2018-2023
Table 15. By Type - Global Hair Loss Medications Sales (K Units), 2024-2029
Table 16. By Application – Global Hair Loss Medications Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Hair Loss Medications Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Hair Loss Medications Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Hair Loss Medications Sales (K Units), 2018-2023
Table 20. By Application - Global Hair Loss Medications Sales (K Units), 2024-2029
Table 21. By Region – Global Hair Loss Medications Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Hair Loss Medications Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Hair Loss Medications Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Hair Loss Medications Sales (K Units), 2018-2023
Table 25. By Region - Global Hair Loss Medications Sales (K Units), 2024-2029
Table 26. By Country - North America Hair Loss Medications Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Hair Loss Medications Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Hair Loss Medications Sales, (K Units), 2018-2023
Table 29. By Country - North America Hair Loss Medications Sales, (K Units), 2024-2029
Table 30. By Country - Europe Hair Loss Medications Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Hair Loss Medications Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Hair Loss Medications Sales, (K Units), 2018-2023
Table 33. By Country - Europe Hair Loss Medications Sales, (K Units), 2024-2029
Table 34. By Region - Asia Hair Loss Medications Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Hair Loss Medications Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Hair Loss Medications Sales, (K Units), 2018-2023
Table 37. By Region - Asia Hair Loss Medications Sales, (K Units), 2024-2029
Table 38. By Country - South America Hair Loss Medications Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Hair Loss Medications Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Hair Loss Medications Sales, (K Units), 2018-2023
Table 41. By Country - South America Hair Loss Medications Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Hair Loss Medications Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Hair Loss Medications Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Hair Loss Medications Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Hair Loss Medications Sales, (K Units), 2024-2029
Table 46. Merck Company Summary
Table 47. Merck Hair Loss Medications Product Offerings
Table 48. Merck Hair Loss Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Merck Key News & Latest Developments
Table 50. Johnson & Johnson Company Summary
Table 51. Johnson & Johnson Hair Loss Medications Product Offerings
Table 52. Johnson & Johnson Hair Loss Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Johnson & Johnson Key News & Latest Developments
Table 54. Gerolymatos International Company Summary
Table 55. Gerolymatos International Hair Loss Medications Product Offerings
Table 56. Gerolymatos International Hair Loss Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Gerolymatos International Key News & Latest Developments
Table 58. Nanogen Company Summary
Table 59. Nanogen Hair Loss Medications Product Offerings
Table 60. Nanogen Hair Loss Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Nanogen Key News & Latest Developments
Table 62. Oxford BioLabs Company Summary
Table 63. Oxford BioLabs Hair Loss Medications Product Offerings
Table 64. Oxford BioLabs Hair Loss Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Oxford BioLabs Key News & Latest Developments
Table 66. Ultrax Labs Company Summary
Table 67. Ultrax Labs Hair Loss Medications Product Offerings
Table 68. Ultrax Labs Hair Loss Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Ultrax Labs Key News & Latest Developments
Table 70. Bayer Company Summary
Table 71. Bayer Hair Loss Medications Product Offerings
Table 72. Bayer Hair Loss Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Bayer Key News & Latest Developments
Table 74. Pharma Medico Company Summary
Table 75. Pharma Medico Hair Loss Medications Product Offerings
Table 76. Pharma Medico Hair Loss Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Pharma Medico Key News & Latest Developments
Table 78. Kirkland Signature Company Summary
Table 79. Kirkland Signature Hair Loss Medications Product Offerings
Table 80. Kirkland Signature Hair Loss Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Kirkland Signature Key News & Latest Developments
Table 82. Phyto Ales Group Company Summary
Table 83. Phyto Ales Group Hair Loss Medications Product Offerings
Table 84. Phyto Ales Group Hair Loss Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Phyto Ales Group Key News & Latest Developments
Table 86. Amplixin Company Summary
Table 87. Amplixin Hair Loss Medications Product Offerings
Table 88. Amplixin Hair Loss Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Amplixin Key News & Latest Developments
Table 90. Keranique Company Summary
Table 91. Keranique Hair Loss Medications Product Offerings
Table 92. Keranique Hair Loss Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Keranique Key News & Latest Developments
Table 94. DS Healthcare Group Company Summary
Table 95. DS Healthcare Group Hair Loss Medications Product Offerings
Table 96. DS Healthcare Group Hair Loss Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. DS Healthcare Group Key News & Latest Developments
Table 98. Hair Loss Medications Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 99. Global Hair Loss Medications Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Hair Loss Medications Production by Region, 2018-2023 (K Units)
Table 101. Global Hair Loss Medications Production by Region, 2024-2029 (K Units)
Table 102. Hair Loss Medications Market Opportunities & Trends in Global Market
Table 103. Hair Loss Medications Market Drivers in Global Market
Table 104. Hair Loss Medications Market Restraints in Global Market
Table 105. Hair Loss Medications Raw Materials
Table 106. Hair Loss Medications Raw Materials Suppliers in Global Market
Table 107. Typical Hair Loss Medications Downstream
Table 108. Hair Loss Medications Downstream Clients in Global Market
Table 109. Hair Loss Medications Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hair Loss Medications Segment by Type in 2022
Figure 2. Hair Loss Medications Segment by Application in 2022
Figure 3. Global Hair Loss Medications Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hair Loss Medications Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Hair Loss Medications Revenue, 2018-2029 (US$, Mn)
Figure 7. Hair Loss Medications Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Hair Loss Medications Revenue in 2022
Figure 9. By Type - Global Hair Loss Medications Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Hair Loss Medications Revenue Market Share, 2018-2029
Figure 11. By Type - Global Hair Loss Medications Sales Market Share, 2018-2029
Figure 12. By Type - Global Hair Loss Medications Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Hair Loss Medications Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Hair Loss Medications Revenue Market Share, 2018-2029
Figure 15. By Application - Global Hair Loss Medications Sales Market Share, 2018-2029
Figure 16. By Application - Global Hair Loss Medications Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Hair Loss Medications Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Hair Loss Medications Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Hair Loss Medications Revenue Market Share, 2018-2029
Figure 20. By Region - Global Hair Loss Medications Sales Market Share, 2018-2029
Figure 21. By Country - North America Hair Loss Medications Revenue Market Share, 2018-2029
Figure 22. By Country - North America Hair Loss Medications Sales Market Share, 2018-2029
Figure 23. US Hair Loss Medications Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Hair Loss Medications Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Hair Loss Medications Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Hair Loss Medications Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Hair Loss Medications Sales Market Share, 2018-2029
Figure 28. Germany Hair Loss Medications Revenue, (US$, Mn), 2018-2029
Figure 29. France Hair Loss Medications Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Hair Loss Medications Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Hair Loss Medications Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Hair Loss Medications Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Hair Loss Medications Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Hair Loss Medications Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Hair Loss Medications Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Hair Loss Medications Sales Market Share, 2018-2029
Figure 37. China Hair Loss Medications Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Hair Loss Medications Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Hair Loss Medications Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Hair Loss Medications Revenue, (US$, Mn), 2018-2029
Figure 41. India Hair Loss Medications Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Hair Loss Medications Revenue Market Share, 2018-2029
Figure 43. By Country - South America Hair Loss Medications Sales Market Share, 2018-2029
Figure 44. Brazil Hair Loss Medications Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Hair Loss Medications Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Hair Loss Medications Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Hair Loss Medications Sales Market Share, 2018-2029
Figure 48. Turkey Hair Loss Medications Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Hair Loss Medications Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Hair Loss Medications Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Hair Loss Medications Revenue, (US$, Mn), 2018-2029
Figure 52. Global Hair Loss Medications Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Hair Loss Medications by Region, 2022 VS 2029
Figure 54. Hair Loss Medications Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 脱毛治療薬の世界市場見通し2023年-2029年(Hair Loss Medications Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆